ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 289 filers reported holding ICU MED INC in Q4 2021. The put-call ratio across all filers is 6.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,274,000 | +695.1% | 19,720 | +463.4% | 0.10% | +427.8% |
Q2 2020 | $286,000 | +153.1% | 3,500 | -21.5% | 0.02% | +200.0% |
Q1 2020 | $113,000 | -40.2% | 4,460 | +340.3% | 0.01% | -50.0% |
Q4 2019 | $189,000 | +200.0% | 1,013 | -90.5% | 0.01% | +100.0% |
Q2 2019 | $63,000 | +350.0% | 10,700 | +613.3% | 0.01% | +500.0% |
Q1 2019 | $14,000 | +1300.0% | 1,500 | +15.4% | 0.00% | – |
Q3 2018 | $1,000 | -99.6% | 1,300 | +52.8% | 0.00% | -100.0% |
Q2 2018 | $249,000 | – | 851 | +325.5% | 0.02% | – |
Q4 2017 | $0 | -100.0% | 200 | -87.5% | 0.00% | -100.0% |
Q2 2017 | $240,000 | +990.9% | 1,597 | +59.7% | 0.01% | +800.0% |
Q1 2017 | $22,000 | -88.0% | 1,000 | -19.6% | 0.00% | -85.7% |
Q4 2016 | $183,000 | +147.3% | 1,244 | +111.9% | 0.01% | +133.3% |
Q3 2016 | $74,000 | +124.2% | 587 | +95.7% | 0.00% | +50.0% |
Q2 2016 | $33,000 | +725.0% | 300 | -92.1% | 0.00% | – |
Q1 2016 | $4,000 | +300.0% | 3,800 | +660.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NUANCE INVESTMENTS, LLC | 1,035,101 | $212,651,000 | 3.97% |
EVR Research LP | 22,000 | $4,520,000 | 3.44% |
Tamarack Advisers, LP | 70,000 | $14,381,000 | 2.95% |
Nitorum Capital, L.P. | 252,668 | $51,908,000 | 2.56% |
PFM Health Sciences, LP | 290,661 | $59,713,000 | 1.82% |
KIRR MARBACH & CO LLC /IN/ | 22,298 | $4,581,000 | 1.33% |
Findlay Park Partners LLP | 671,136 | $137,878,000 | 0.96% |
PURA VIDA INVESTMENTS, LLC | 148,548 | $30,518,000 | 0.87% |
Redmile Group, LLC | 224,154 | $46,050,000 | 0.65% |
Canvas Wealth Advisors, LLC | 5,177 | $1,064,000 | 0.62% |